| Literature DB >> 31484468 |
Angus Lindsay1, Gregory Baxter-Parker2, Steven P Gieseg2,3.
Abstract
We performed a systematic review of the literature to evaluate pterins as biomarkers of mechanical and impact-induced trauma. MEDLINE and Scopus were searched in March 2019. We included in vivo human studies that measured a pterin in response to mechanical or impact-induced trauma with no underlying prior disease or complication. We included 40 studies with a total of 3829 subjects. Seventy-seven percent of studies measured a significant increase in a pterin, primarily neopterin or total neopterin (neopterin + 7,8-dihydroneopterin). Fifty-one percent of studies measured an increase within 24 h or trauma, while 46% measured increases beyond 48 h. Pterins also showed promise as predictors of post-trauma complications such as sepsis, multi-organ failure and mortality. Exercise-induced trauma and traumatic brain injury caused an immediate increase in neopterin or total neopterin, while patients of multiple trauma had elevated pterin levels that remained above baseline for several days. Pterin concentration changes in response to surgery were variable with patients undergoing cardiac surgery having immediate and sustained pterin increases, while hysterectomy, liver resection or hysterectomy showed no change. This review provides systematic evidence that pterins, in particular neopterin and total neopterin, increase in response to multiple forms of mechanical or impact-induced trauma.Entities:
Keywords: biopterin; exercise; neopterin; surgery; tetrahydrobiopterin; trauma; traumatic brain injury
Year: 2019 PMID: 31484468 PMCID: PMC6780259 DOI: 10.3390/jcm8091383
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1A flow diagram detailing the inclusion/exclusion identification of studies in this systematic review.
Studies measuring pterins following impact-induced trauma in exercise and sport.
| Authors | Year | Pterin | Media | Population | Intervention | Outcome |
|---|---|---|---|---|---|---|
| Lindsay et al. [ | 2015 | NP and Total NP | Urine corrected with specific gravity | Elite amateur rugby players; n = 11; median height = 1.87 m; median weight = 96 kg | Rugby game | - NP ↑ (p = 0.02) |
| Lindsay et al. [ | 2015 | Total NP | Urine corrected with specific gravity | Professional rugby players; n = 37; height = 1.81– 2.01 m; weight = 92.9– 112.3 kg; age = 23.7–27.5 years | Several rugby games separated by player position | ↑ (43.6–109.6%) within 60 min post-game |
| Lindsay et al. [ | 2015 | Total NP | Urine corrected with specific gravity | Professional rugby players; n = 37; height = 1.86 ± 0.07 m; weight = 104.5 ± 9.3 kg; age = 26 ± 3.5 years | Rugby game – data from several games compiled together during a season | ↑ (64%) within 60 min post-game. Still significantly elevated 36 hours post-game |
| Lindsay et al. [ | 2015 | Total NP | Urine corrected with specific gravity | Professional rugby players; n = 37; height = 1.86 ± 0.07 m; weight = 104.5 ± 9.3 kg; age = 26 ± 3.5 years | Rugby season (20 weeks) | No change throughout the season |
| Lindsay et al. [ | 2015 | NP and Total NP | Urine corrected with specific gravity | Semi-professional rugby players; n = 24; height = 1.87 ± 0.06 m; weight = 103.3 ± 11.6 kg; age = 24.2 ± 2.9 years | Three rugby games separated by a week | - NP ↑ (p < 0.002) |
| Lindsay et al. [ | 2015 | NP and Total NP | Urine corrected with specific gravity | Semi-professional MMA; n = 10; height = 1.77 ± 0.04 m; weight = 79.5 ± 0.5 kg; age = 27.3 ± 3.3 years | MMA fight | - NP ↑ (p = 0.02) 1 h post-fight but was not different up to 48 hours post |
| Lindsay et al. [ | 2016 | NP, 7,8-NP, BP, Total BP, XP | Urine corrected with specific gravity | Professional rugby players; n = 14–23; height = 1.86 ± 0.07 m; weight = 104.5 ± 9.3 kg; age = 26 ± 3.5 years | Rugby game—four separate games separated by a week | - NP ↑ (1.37–2.82 fold) |
| Lindsay et al. [ | 2016 | NP and Total NP | Urine corrected with specific gravity | Semi-professional MMA; n = 14; height = 1.78 ± 0.08 m; weight = 84.3 ± 12.9 kg; age = 26.6 ± 8.2 years | Six-week MMA training camp | NP and Total NP ↑ |
| Lindsay et al. [ | 2017 | NP and Total NP | Urine corrected with specific gravity | Semi-professional MMA; n = 15; height = 1.8 ± 0.09 m; weight = 88.8 ± 14.5 kg; age = 28.3 ± 5.7 years | MMA training session | - NP ↑ 4.07 fold and remained elevated up to 24 hours post |
BP; biopterin, MMA; mixed martial arts or artists, NP; Neopterin, Total BP; BP + BH2 (7,8-dihydrobiopterin) + BH4 (5,6,7,8-tetrahydrobiopterin), Total NP; NP + 7,8-dihydroneopterin, XP; xanthopterin.
Studies measuring pterins following surgery.
| Authors | Year | Pterin | Media | Population | Categorization | Outcome |
|---|---|---|---|---|---|---|
| Grob et al. [ | 1988 | NP | Serum | Consecutive patients hospitalised for selective surgery; n = 35/surgery (10 females and 25 males); age 18–72 years | Herniotomy, cholecystectomy, major surgery on rectum or colon, aorto-coronary bypass or ypsilon graft | No change within 4-days post-surgery among all surgery types |
| Pilz et al. [ | 1994 | NP | Plasma | Patients excluding heart transplantation and pacemaker implantation; n = 110; age = 58.4 ± 1.1 (no complications) and 61.0 ± 2.3 (septic complication) | Elective cardiac surgery | - ↑ after day 1 and remained elevated after 3 days |
| Bogă et al. [ | 2000 | NP | Plasma | Patients excluding those undergoing emergency surgery, or having a diagnosed systemic disorder such as hemostatic defect, hypertension, diabetes or renal failure; n = 40 (10 female and 30 male); age = 57.8 ± 8.9 (study group) and 61.2 ± 7.5 years (control group) | Coronary artery bypass grafting—with or without ultrafiltration | - mean NP ↓ after surgery and ↑ 3- and 20-hours post-surgery (statistical analysis not provided) |
| Jerin et al. [ | 2002 | NP | Serum | Patients suffered from malignant disease (hepatic metastases of colonic cancer, hepatocellular cancer, gallbladder cancer or cholangiocarcinoma) or non-malignant disease (echinococcus cysts, liver haemangioma, liver adenoma or Carroli disease); n = 27 (16 female and 11 male); age 5–77 years | Liver resection | - No change 24-hours post-surgery |
| Schwab et al. [ | 2004 | NP | Serum | No exclusions; n = 101; height = 162– 196 cm; weight = 53–108 kg; age = 18–90 years | Hernia surgery—local or general anaesthetic and either unilateral or bilateral repair | NP ↑ significantly 1 h post-surgery but no difference between the surgical groups. NP was still elevated 72 hours post-surgery |
| Brkić et al. [ | 2006 | NP | Serum | Patients excluding those undergoing | Cardiac surgery with or without cardiopulmonary bypass | - Both surgeries ↑ NP at 24 and 72 h post-surgery with bypass further ↑ concentrations |
| Skrak et al. [ | 2007 | NP | Serum | Patients with a congenital heart defect; n = 152; age = 11 days–13 years; weight = 3.3–44 kg | Cardiac surgery with cardiopulmonary bypass | NP ↑ in neonates and infants/children after one day and remained elevated after 2 days |
| Forrest et al. [ | 2011 | NP | Serum | No data on inclusion – control group were major non-thoracic surgery patients; n = 28 (3 female and 25 male); age = 60.2 ± 1.7 years | Cardiac bypass surgery | - Cardiac surgery ↓ NP compared to baseline but ↑ 6 days-post |
| Osse et al. [ | 2012 | Total NP BH4 | Plasma | Patients excluding those whom required deep cooling, circulatory arrest, or emergency surgery; n = 125 provided pterin samples; median age = 76 years | Cardiac surgery—coronary artery bypass graft or valve surgery | - NP ↑ following surgery. Elevated pre-surgical NP associated with a greater risk of becoming delirious after surgery |
| Hol et al. [ | 2014 | Total NP | Plasma | Patients > 18 years of age and ASA classification I-III; n = 28 (all female);age = 62 ± 12 and 44 ± 9 years; height = 166 ± 5 and 167 ± 6 cm; weight = 71 ± 10 and 71 ± 7 | Vulvectomy or abdominal hysterectomy | - Surgery ↓ total NP for both surgical groups up to 24 hours post |
| Berg et al. [ | 2015 | NP | Plasma | Patients excluding those with infectious blood, active endocarditis, underwent off-pump surgery, intercurrent infection or elevated levels of CRP; n = 1018 (282 female and 736 male); age = 67–75 years | Cardiac surgery | Improved the accuracy of predicting cardiac dysfunction after surgery |
| Enger et al. [ | 2017 | NP | Plasma | Patients without preoperative dialysis or missing serum creatinine; n = 1015 (282 female and 733 male);age = 66–76 years;body mass index = 26.6–29.4 kg/m2 | Cardiac surgery with cardiopulmonary bypass | Independent predictor of CSA-AKI |
| Christensen et al. [ | 2018 | NP | Plasma | Patients had at least one obesity related | Laparoscopic sleeve gastrectomyor biliopancreatic diversion with duodenal switch | No change up to 12 months post-surgery |
| Baxter-Parker et al. [ | 2019 | NP and Total NP | Urine | Patients were excluded if below 18 or above 80 years of age, smokers, or patients having recently received a diagnosis of cancer.; n = 19; age = 62.68 ± 8.97 years. Control subjects; n = 20; age = 37.7 ± 12.9 | Knee replacement surgery | - NP ↑ two days post-surgery |
ASA; American Society of Anesthesiologists, BH4 (5,6,7,8-tetrahydrobiopterin), CRP; C-reactive protein, CSA-AKI; acute kidney injury following cardiac surgery, NP; Neopterin, T2D; type 2 diabetes, Total BP; BP + BH2 (7,8-dihydrobiopterin) + BH4 (5,6,7,8-tetrahydrobiopterin), Total NP; NP + 7,8-dihydroneopterin.
Studies measuring pterins following traumatic brain injury.
| Authors | Year | Pterin | Media | Population | Categorization | Outcome |
|---|---|---|---|---|---|---|
| Lenzlinger et al. [ | 2001 | NP | CSF and Serum | Patients presented with a Glasgow Coma Score at admission equal to or less | Isolated TBI | - CSF NP ↑ in 78% of patients and remained elevated 21 days post-surgery (1.88–39.48 ng/mL) |
| Lenzlinger et al. [ | 2002 | NP | CSF | Patients had a Glasgow Coma Scale (GCS) score equal to or less than 8 at admission and alterations in the computer aided tomography; n = 10 (4 female and 6 male); age 18–65 years | Severe TBI | No directly stated values but examination of the results suggest values ranged from approximately 0–40 ng/mL |
CSF; cerebrospinal fluid, NP; Neopterin, TBI; traumatic brain injury.
Studies measuring pterins following multiple trauma or bone fracture.
| Authors | Year | Pterin | Media | Population | Categorization | Outcome |
|---|---|---|---|---|---|---|
| Brandl et al. [ | 1989 | NP | Serum | Injures were initially quantified according to the ISS; n = 51 but NP measured in 26 | Multiple-trauma | NP higher in non-survivors |
| Krüger et al. [ | 1991 | NP | Serum | Patients had no acute disease process prior to trauma. | Polytrauma | NP ↑ after trauma (values not provided) |
| Strohmaier et al. [ | 1992 | NP | Plasma | Case study—38-year-old female with ISS of 66 | Trauma-accident victim—leg amputation | NP ↑ during the clinical course |
| Waydhas et al. [ | 1992 | NP | Plasma | Patients admitted to the emergency department with less than 6 hours between accident and admission to the emergency department; between 16 and 70 years of age; and severe injuries of at least two body regions (head/brain, thorax, abdomen, skeletal system) or three major fractures (ISS ≥ 32; n = 100 (36 female and 74 male); age = 38 years | Trauma | - NP ↑ within 24 h |
| Roumen et al. [ | 1995 | NP | Urine (creatinine standardized) | Patients were included in the study if the ISS was ≥ 33; n = 56 | Multiple trauma | NP higher in patients with multiple organ failure once it had become established 8–10 days post-trauma |
| Hobisch-Hagen et al. [ | 2001 | NP | Serum | Patients aged >19 yrs, expected, stay in the ICU > 72 h Partial pressure of oxygen (PaO2) > 75 torr during the ICU stay, no renal or hepatic failure, no history of hematopoietic or endocrinological disorder, and ISS ≥ 30; n = 23 (5 female and 18 male); age = 19–59 years | Multiple mechanical trauma | NP low after admission but ↑ until 9 days post-trauma |
| Hensler et al. [ | 2003 | NP | Plasma | Patients were ≥ 16 years of age, ISS ≥ 16 and an expected minimum of survival for ≥ 3 days. Patients with acquired or inherited immunodeficiencies and patients receiving immunosuppressive therapy were excluded; n = 137 (35 female and 102 male); age = 38.5 ± 16.6 years | Trauma, including brain injury | - NP ↓ post-trauma and ↑ 1- and 2-days post |
| Egger et al. [ | 2004 | NP | Blood – not specified | Patients who died or who were transported abroad where the further course could not be followed were excluded from the study. Eight patients with an ISS of ≤ 20, 10 patients with an ISS of 21–30, and eight patients with an ISS > 30 were included; n = 26 (8 female and 18 male); age = 17–77 years; | Multiple trauma | - NP ↑ in some patients (unclear at what time point) |
| Walsh et al. [ | 2005 | NP | Urine (creatinine standardized) | Patients aged 18 to 50 with an ISS > 20 were included. Patients that received corticosteroids for head injuries or died within 1 week from severe mechanical injury were excluded | Severe injury | - mean NP ↑ 1-day post-trauma |
| Ploder et al. [ | 2006 | NP | Plasma | Patients were aged between 18 and 80 years and multiple trauma, defined as injury to two or more anatomic areas (head, chest, abdomen, or pelvis) or to one anatomic area and to two long bones (femur, tibia, or humerus). Exclusion criteria were isolated head injury, known immunosuppressive therapy, or known HIV infection; n = 21; age = 38.7 ± 15.8 years. Mean ISS = 40.6 ± 11.6 | Multiple trauma | NP continually increased above entry to ICU for 14 days and was higher in non-survivors |
| Ploder et al. [ | 2008 | NP | Serum | Patients with an APACHE score of 18.9 ± 6.75 and ISS score of 39 ± 13.1; n = 18 (4 female and 14 male); age = 45 ± 19 years. | Trauma | - NP ↑ in patients with 79.8% above the 95th percentile of healthy controls |
| Ploder et al. [ | 2009 | NP | Serum | Patients aged between 22 - 77 years and evidence of a multiple trauma (ISS = 39.1 ± 13.1; APACHE = 17.5 ± 6.5). Exclusion criteria were known immunosuppressive therapy, known HIV infection or any other chronic disease; n = 15 (3 female and 12 male); age = 40.4 ± 17.2 years | Trauma | - NP ↑ compared to controls |
| Ploder et al. [ | 2010 | NP | Plasma | Patients admitted to ICU. APACHE score: 18.9 ± 6.75, ISS: 39 ± 13.1; n = 18 (4 female and 14 male); age = 45 ± 19 years | Trauma | ↑ NP compared to control subjects but timeline could not be determined |
| Hall et al. [ | 2016 | Total NP | CSF and serum | Patients included if the fracture was caused by a low energy trauma (defined as a fall from less than 1 meter). Patients were excluded if they were under the age of 60, were nursing home residents, had significant Parkinson’s disease or had malignant or other comorbid disease such that prognosis was less than one year; n = 139 | Hip fracture | - NP values above upper end of normal |
| Larsen et al. [ | 2017 | NP | Plasma | Patients aged 75 years and older, free of medication and diseases affecting the immune system (e.g., cancers, autoimmune disorders), absence of prior physical disabilities and, absence of cognitive disorders; n = 60 | Hip fracture followed by surgery | Predictor of mortality one-year post-fracture and correlates negatively with time of survival after fracture surgery |
CRP; C-reactive protein, CSF; cerebrospinal fluid, HIV; human-immunodeficiency virus, ICU; intensive care unit, ISS; injury severity score, NP; Neopterin, T2D; type 2 diabetes, Total NP; NP + 7,8-dihydroneopterin.
Figure 2(A) Percent of studies that measured an increase, decrease or no change, or did not state or measure changes in pterins. (B) Studies that reported a change in pterin concentration within 24 hours of trauma or (C) greater than 48 hours post-trauma.